241 related articles for article (PubMed ID: 34545430)
1. A network meta-analysis of randomized controlled trials comparing the effectiveness and safety of voclosporin or tacrolimus plus mycophenolate mofetil as induction treatment for lupus nephritis.
Lee YH; Song GG
Z Rheumatol; 2023 Sep; 82(7):580-586. PubMed ID: 34545430
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
[TBL] [Abstract][Full Text] [Related]
3. Multitarget therapy versus monotherapy as induction treatment for lupus nephritis: A meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2022 Oct; 31(12):1468-1476. PubMed ID: 35986446
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment response and serious infection using tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis.
Song GG; Lee YH
Int J Clin Pharmacol Ther; 2020 Oct; 58(10):550-556. PubMed ID: 32691727
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Z Rheumatol; 2017 Dec; 76(10):904-912. PubMed ID: 27638015
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of immunosuppressive drugs induction therapy for lupus nephritis: a systematic review and network meta-analysis.
Dong Y; Shi J; Wang S; Liu Y; Yu S; Zhao L
Ren Fail; 2023; 45(2):2290365. PubMed ID: 38087473
[TBL] [Abstract][Full Text] [Related]
7. Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis.
Lee YH; Song GG
Pharmacology; 2022; 107(9-10):439-445. PubMed ID: 35609529
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis.
Jiang N; Jin S; Yu C; Zhao J; Wang Q; Tian X; Li M; Zeng X
Front Immunol; 2023; 14():1232244. PubMed ID: 37901212
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of low-dose and high-dose cyclophosphamide as induction therapy for lupus nephritis: a network meta-analysis.
Bae SC; Lee YH
Z Rheumatol; 2019 Jun; 78(5):467-473. PubMed ID: 30039177
[TBL] [Abstract][Full Text] [Related]
10. Relative efficacy and safety of calcineurin inhibitor, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis.
Lee YH; Song GG
Z Rheumatol; 2024 Feb; 83(Suppl 1):140-147. PubMed ID: 37278824
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment for proliferative lupus nephritis.
Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a meta-analysis.
Lee YH; Song GG
Z Rheumatol; 2023 Nov; 82(9):754-762. PubMed ID: 36607421
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis.
Li K; Yu Y; Gao Y; Zhao F; Liang Z; Gao J
Front Immunol; 2022; 13():859380. PubMed ID: 35444666
[TBL] [Abstract][Full Text] [Related]
14. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Int J Clin Pharmacol Ther; 2022 Feb; 60(2):97-105. PubMed ID: 34622770
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of rituximab, mycophenolate, and cyclophosphamide in active antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Int J Clin Pharmacol Ther; 2021 Oct; 59(10):645-653. PubMed ID: 34338191
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
[TBL] [Abstract][Full Text] [Related]
18. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.
Singh JA; Hossain A; Kotb A; Wells G
BMC Med; 2016 Sep; 14(1):137. PubMed ID: 27623861
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.
Liu LL; Jiang Y; Wang LN; Yao L; Li ZL
Drugs; 2012 Jul; 72(11):1521-33. PubMed ID: 22818016
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria.
Menn-Josephy H; Hodge LS; Birardi V; Leher H
Clin J Am Soc Nephrol; 2024 Mar; 19(3):309-318. PubMed ID: 38110196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
